Market Cap 4.20B
Revenue (ttm) 4.79B
Net Income (ttm) -317.00M
EPS (ttm) N/A
PE Ratio 23.96
Forward PE 23.17
Profit Margin -6.62%
Debt to Equity Ratio 0.75
Volume 899,699
Avg Vol 870,098
Day's Range N/A - N/A
Shares Out 353.37M
Stochastic %K 24%
Beta 0.58
Analysts Sell
Price Target $14.27

Latest News on BLCO

Bausch + Lomb Announces First-Quarter 2025 Results

Apr 30, 2025, 6:57 AM EDT - 14 days ago

Bausch + Lomb Announces First-Quarter 2025 Results


Bausch + Lomb Corporation (BLCO) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 12:19 PM EST - 2 months ago

Bausch + Lomb Corporation (BLCO) Q4 2024 Earnings Call Transcript


Bausch & Lomb to shake up contact lenses with deal off the table

Feb 19, 2025, 9:16 AM EST - 2 months ago

Bausch & Lomb to shake up contact lenses with deal off the table


Bausch Health Provides Update on Strategic Alternatives

Feb 6, 2025, 7:05 AM EST - 3 months ago

Bausch Health Provides Update on Strategic Alternatives

BHC


Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid

Oct 14, 2024, 12:20 PM EDT - 7 months ago

Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid


Overlooked Stock: BLCO

Sep 16, 2024, 5:07 PM EDT - 8 months ago

Overlooked Stock: BLCO


Bausch + Lomb Stock Jumps Amid Reports Of A Sale

Sep 16, 2024, 1:16 PM EDT - 8 months ago

Bausch + Lomb Stock Jumps Amid Reports Of A Sale


Bausch + Lomb Corporation (BLCO) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:42 PM EDT - 10 months ago

Bausch + Lomb Corporation (BLCO) Q2 2024 Earnings Call Transcript


Bausch + Lomb Announces First-Quarter 2024 Results

May 1, 2024, 6:58 AM EDT - 1 year ago

Bausch + Lomb Announces First-Quarter 2024 Results


Bausch & Lomb's stock soars 11% after earnings beat

Feb 21, 2024, 8:27 AM EST - 1 year ago

Bausch & Lomb's stock soars 11% after earnings beat


Bausch Health's Bausch + Lomb to Acquire Novartis' XIIDRA(R)

Jun 30, 2023, 8:30 AM EDT - 2 years ago

Bausch Health's Bausch + Lomb to Acquire Novartis' XIIDRA(R)

BHC NVS